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Original Article
Diagnostic value of MRI signs in
differentiating Ewing sarcoma
from osteomyelitis
O¨mer Kasalak1, Jelle Overbosch1, Hugo JA Adams2 ,
Amelie Dammann1, Rudi AJO Dierckx1, Paul C Jutte3
and Thomas C Kwee1
Abstract
Background: The value of magnetic resonance imaging (MRI) signs in differentiating Ewing sarcoma from osteomyelitis
has not be thoroughly investigated.
Purpose: To investigate the value of various MRI signs in differentiating Ewing sarcoma from osteomyelitis.
Material and Methods: Forty-one patients who underwent MRI because of a bone lesion of unknown nature with a
differential diagnosis that included both Ewing sarcoma and osteomyelitis were included. Two observers assessed several
MRI signs, including the transition zone of the bone lesion, the presence of a soft-tissue mass, intramedullary and
extramedullary fat globules, and the penumbra sign.
Results: Diagnostic accuracies for discriminating Ewing sarcoma from osteomyelitis were 82.4% and 79.4% for the
presence of a soft-tissue mass, and 64.7% and 58.8% for a sharp transition zone of the bone lesion, for readers 1 and 2
respectively. Inter-observer agreement with regard to the presence of a soft-tissue mass and the transition zone of the
bone lesion were moderate (k¼ 0.470) and fair (k¼ 0.307), respectively. Areas under the receiver operating charac-
teristic curve of the diameter of the soft-tissue mass (if present) were 0.829 and 0.833, for readers 1 and 2 respectively.
Mean inter-observer difference in soft-tissue mass diameter measurement limits of agreement was 35.0 75.0mm.
Diagnostic accuracies of all other MRI signs were all< 50%.
Conclusion: Presence and size of a soft-tissue mass, and sharpness of the transition zone, are useful MRI signs to
differentiate Ewing sarcoma from osteomyelitis, but inter-observer agreement is relatively low. Other MRI signs are of no
value in this setting.
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Introduction
Ewing sarcoma is a highly aggressive bone and soft-
tissue tumor (primarily bone) with a peak incidence in
children and young adults (<30 years), while it is par-
ticularly rare among Asian and black populations (1,2).
The annual incidence of Ewing sarcoma in the Western
world has been reported to be around 2.93/1,000,000
cases (3). Ewing sarcoma in bone may mimic osteomye-
litis clinically (both may present with fever, increased
serum inﬂammatory markers, and bone pain) and
on imaging examinations (both may present with
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aggressive periosteal reaction, cortical destruction, and
articular involvement) (4). In fact, it has been reported
that up to 50% of subacute osteomyelitis cases in chil-
dren are confused with tumor (5). Timely and accurate
diﬀerentiation between these two entities, however, is
important because treatment and outcome are com-
pletely diﬀerent (1,6).
Only two previous studies have speciﬁcally focused
on the important diﬀerentiation between Ewing
sarcoma and osteomyelitis (7,8). In a study by
Henninger et al. (7) that investigated six magnetic res-
onance imaging (MRI) features in 18 patients with
osteomyelitis and ten patients with Ewing sarcoma, a
sharp and deﬁned margin of the bone lesion was
reported to be the most signiﬁcant feature that diﬀer-
entiated Ewing sarcoma from osteomyelitis. However,
in another study by McCarville et al. (8) that evaluated
36 radiographic and MRI parameters in 32 patients
with osteomyelitis and 31 patients with Ewing sarcoma,
it was reported that most individuals with Ewing sar-
coma or osteomyelitis had a wide transition zone on
MRI and that this feature did not predict the diagnosis
(8). The latter study also reported that a soft-tissue
mass was more likely to occur in association with
Ewing sarcoma than with osteomyelitis and that no
other clinical or imaging features (except ethnicity)
were predictive of prognosis (8). Besides the partially
conﬂicting results between Henninger et al.’s and
McCarville et al.’s studies (7,8), one of the main limi-
tations of these two studies is that they only included
Ewing sarcoma and osteomyelitis cases, and that other
diﬀerential diagnostic entities were excluded (7,8). This
limits the clinical applicability of their results as this is
often not the situation which clinicians face. Therefore,
further research is necessary to clarify the true diagnos-
tic value of the MRI signs that were proposed
by Henninger et al. and McCarville et al. (7,8).
Expanding on these previous studies, it can be hypothe-
sized that the size of the soft-tissue mass adjacent to the
involved bone (if present) may also be of importance, in
that the soft-tissue mass associated with Ewing sarcoma
may show more expansion eccentric to the long axis of
the bone than in osteomyelitis. Other potentially useful
MRI signs in this setting are the so-called ‘‘penumbra
sign’’ (i.e. a peripheral layer surrounding a cavity in
either the bone marrow or adjacent soft tissues that is
hyperintense on unenhanced T1-weighted (T1W)
images and enhances intensely after administration of
gadolinium (9)), and the presence of intramedullary or
extramedullary fat globules (i.e. one or more localized
fat collections in the bone marrow or adjacent soft-
tissue (10)), all of which have been suggested to indicate
osteomyelitis. However, the penumbra sign was not
seen in any of the osteomyelitis cases in Henninger
et al.’s study (7) and in only two osteomyelitis cases
in McCarville et al.’s study (8). Furthermore, the diag-
nostic value of the presence of intra- or extramedullary
fat globules in diﬀerentiating Ewing sarcoma from
osteomyelitis has never been investigated.
The purpose of this study was therefore to investi-
gate the diagnostic value of several potentially useful
MRI signs in diﬀerentiating Ewing sarcoma from
osteomyelitis in patients who presented with a bone
lesion of unknown nature with a diﬀerential diagnosis
that included both Ewing sarcoma or osteomyelitis.
Material and Methods
Study design and patients
This retrospective study was approved by the local
institutional review board, and the requirement for
written informed consent was waived. The Picture
Archiving and Communication System (PACS) of a
tertiary referral center for bone tumors was searched
for all patients who underwent MRI between 2010
and 2016 because of a bone lesion of unknown nature
with a diﬀerential diagnosis that included both Ewing
sarcoma and osteomyelitis. Inclusion criteria for this
study were: patients aged 30 years and younger; pres-
ence of a bone lesion on radiography of unknown
nature with both Ewing sarcoma and osteomyelitis in
the diﬀerential diagnosis; availability of an MRI exam-
ination of the bone lesion in the PACS system; and
biopsy (either percutaneous computed tomography
[CT]- or ultrasound-guided or open surgical); or at
least six months follow-up as reference standard.
Patients who were eventually diagnosed with a disease
other than Ewing sarcoma or osteomyelitis were also
eligible for inclusion. Exclusion criteria for this study
were: biopsy or surgery before MRI was performed;
pathologically or microbiologically proven diagnosis
before MRI was performed; extra-osseous Ewing sar-
coma; craniospinal Ewing sarcoma; presence of meta-
static disease on other imaging modalities before MRI
was performed; and patients with clinical ﬁndings
highly suggestive of osteomyelitis before MRI was per-
formed (such as bacteremia, history of osteomyelitis,
cutaneous defects/ﬁstulae, recent musculoskeletal sur-
gery, and presence of osteosynthetic or prosthetic
material).
MRI acquisition
MRI scans were performed using clinical 1.5-T MRI
systems. Eleven of 41 patients who were eventually
included had undergone MRI before referral to our
hospital. Therefore, MRI protocols were not uniform.
Nevertheless, all included patients were scanned
with unenhanced T1-weighted (T1W), T2-weighted
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(T2W), and fat-suppressed T2W sequences.
Gadolinium-enhanced sequences were acquired in 36
of 41 patients (ﬁve patients who were eventually diag-
nosed with osteomyelitis did not undergo gadolinium-
enhanced MRI). Applied slice thicknesses were in the
range of 0.9–4.0mm. Sequences or reconstructed
images (in case a three-dimensional isotropic MRI
sequence was acquired) were oriented in at least two
directions with regard to the involved bone.
MRI evaluation
MRI datasets were reviewed in a random order by two
radiologists (O¨K and JO, with four years and nine years
of experience in musculoskeletal MRI, respectively)
using a PACS workstation (Carestream Vue PACS ver-
sion 11.4.1.1102, Carestream Health, Inc, Rochester,
NY, USA). Both readers knew the age and gender of
each patient and were aware of the fact that MRI was
performed because of a bone lesion of unknown nature
and a diﬀerential diagnosis of both Ewing sarcoma and
osteomyelitis. However, both readers were blinded to
each other’s assessments, original MRI reports, ﬁnal
diagnosis, and other clinical, pathological, and follow-
up ﬁndings. Radiographs, CT scans, and other imaging
tests performed before MRI, if available, were not
reviewed during MRI evaluation. MRI scans were eval-
uated with regard to the transition zone of the bone
lesion (sharp vs. unsharp on T1W images in compari-
son to fat-suppressed T2W images) (7), presence of a
soft-tissue mass (i.e. a lobular or inﬁltrative structure
located in the adjacent soft-tissue that contains solid
material [is not completely ﬂuid on a water-sensitive
sequence] and has areas that enhance after gadolinium
administration) (8), the maximum diameter of the soft-
tissue mass perpendicular to the long axis of the
involved bone (caliper measurement), the presence of
the penumbra sign (i.e. a peripheral layer surrounding a
cavity in either the bone marrow or adjacent soft tissues
that is hyperintense on unenhanced T1W images and
enhances intensely after administration of gadolinium)
(9), and the presence of intramedullary and/or extrame-
dullary fat globules (deﬁned as T1-hyperintense foci
within the involved bone marrow or adjacently
involved soft tissue) (10). In case of two lesions in the
MRI ﬁeld of view in the same patient, only the largest
lesion was analyzed. The two readers were provided
with examples of MRI scans that were published in
previous studies to facilitate the interpretation of
these MRI signs (7–10).
Reference standard
Percutaneous CT- or ultrasound-guided biopsy with
needle sizes in the range of 9–18 gauge (depending on
the preference of the attending radiologist as deter-
mined in each individual patient) or open surgical
biopsy (performed by an orthopedic surgeon) followed
by histopathological examination (performed by a
pathologist with expertise in bone tumors) and tissue
cultures (interpreted by a microbiologist) served as ref-
erence standard. If biopsy was not performed or incon-
clusive, clinical and imaging follow-up of at least six
months served as reference standard.
Statistical analysis
Diagnostic accuracy (as global measure of diagnostic
performance), sensitivity, speciﬁcity, positive predictive
value (PPV), and negative predictive value (NPV) of
each of the investigated MRI signs for the discrimin-
ation between Ewing sarcoma from osteomyelitis were
calculated (excluding other diagnostic entities), along
with 95% conﬁdence intervals (CIs). Receiver operating
characteristic (ROC) analysis was performed to deter-
mine the value of the diameter of the soft-tissue mass in
patients who presented with a soft-tissue mass adjacent
to the involved bone. The area under the ROC curve
(AUC) and optimal cut-oﬀ value with corresponding
sensitivity and speciﬁcity were calculated. The same
analyses were then repeated for Ewing sarcoma or
other malignancy vs. osteomyelitis or other benign
lesions. Inter-observer agreement with regard to the
evaluated MRI signs was analyzed using the
unweighted k statistic, deﬁned as poor (<0.2), fair
(>0.2 to 0.4), moderate (>0.4 to 0.6), good (>0.6
to 0.8), and very good (>0.8 to 1) agreement. Inter-
observer agreement with regard to the measurement of
the soft-tissue mass diameter was determined as mean
absolute diﬀerence (bias) and 95% CI of the mean dif-
ference (limits of agreement) according to the methods
of Bland and Altman (11). Statistical analyses were




A total of 84 patients were potentially eligible for inclu-
sion. However, 25 patients were excluded because of
either already proven or clinical ﬁndings highly suggest-
ive of osteomyelitis, ﬁve patients were excluded because
of extra-osseous Ewing sarcoma, ﬁve patients were
excluded because of lack of an MRI scan in the
PACS, three patients were excluded because of cra-
niospinal Ewing sarcoma, three patients with Ewing
sarcoma were excluded because of presence of meta-
static disease on other imaging modalities before MRI
was performed, and two patients were excluded because
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of pathologically proven diagnosis before MRI was
performed (one Ewing sarcoma and one eosinophilic
granuloma). Thus, 41 patients (19 boys/men, 22 girls/
women, all of Caucasian ethnicity; mean age¼ 11.2
5.3 years; age range¼ 0–25 years) were ﬁnally included.
The bone lesions were located in the femur (n¼ 9),
tibia (n¼ 9), pelvic bone (n¼ 8), clavicle (n¼ 5),
humerus (n¼ 2), radius (n¼ 2), ﬁbula (n¼ 2), clavicle
and rib (n¼ 1), rib (n¼ 1), femur and tibia (n¼ 1), and
talus (n¼ 1). The basic characteristics of included
patients are shown in Table 1.
Reference standard
Diagnosis was based on percutaneous CT- or ultra-
sound-guided biopsy in 25 patients (Ewing sarcoma:
n¼ 8; osteomyelitis: n¼ 10; other malignancy: n¼ 3;
other benign lesion: n¼ 4), open surgical biopsy in 12
patients (Ewing sarcoma: n¼ 6; osteomyelitis: n¼ 6),
and clinical and imaging follow-up (minimum
follow-up time¼ 18 months) without biopsy in four
patients (osteomyelitis: n¼ 4). Final diagnoses were
Ewing sarcoma in 14 patients, osteomyelitis in 20
patients (of which ten bacterial osteomyelitis and ten
non-bacterial osteitis), osteosarcoma in two patients,
eosinophilic granuloma in two patients, acute lympho-
blastic leukemia (without blastic cells in peripheral
blood tests) in one patient, aneurysmatic bone cyst in
one patient, and stress fracture in one patient.
Diagnostic performance MRI signs
Measures of diagnostic performance are shown in
Tables 2 and 3. Diagnostic accuracies for discriminat-
ing Ewing sarcoma from osteomyelitis were 64.7% and
58.8% for a sharp transition zone of the bone lesion, and
82.4% and 79.4% for the presence of a soft-tissue mass,
for readers 1 and 2, respectively. Diagnostic accuracies
for discriminating Ewing sarcoma or malignancy from
osteomyelitis or other benign lesions were 68.3% and
Table 1. Basic characteristics of included patients.
Characteristic Ewing sarcoma Osteomyelitis* Other malignancyy Other benign lesionsz
Patients (n) 14 20 3 4
Mean age SD (years) 13.4 4.9 10.6 5.8 7.7 3.2 8.8 2.5
Age range (years) 5–25 0–23 4–10 5–12
Male/female (n) 8/6 9/11 0/3 2/2
Affected bones (n)
Femur 2 5 1 1
Tibia 3 4 – 2
Pelvis 5 2 1 –
Clavicle 1 4 – –
Humerus 1 – 1 –
Radius – 1 – 1
Fibula 1 1 – –
Clavicle and rib – 1 – –
Rib 1 – – –
Femur and tibia – 1 – –
Talus – 1 – –
Locations within long bones§
Diaphysis only 2 5 2
Metaphysis only 3 –
Diaphysis and metaphysis 3 2 – 2
Metaphysis and epiphysis – 2 – –
Dia-, meta-, and epiphysis 3 5 2 –
Involvement of epiphysial plate** 2 3 2 –
*Bacterial osteomyelitis (n¼ 10) and non-bacterial osteitis (n¼ 10).
yOsteosarcoma (n¼ 2) and acute lymphoblastic leukemia (n¼ 1).
zEosinophilic granuloma (n¼ 2), aneurysmatic bone cyst (n¼ 1), and stress fracture (n¼ 1).
§In patients with bone lesions in the clavicle, humerus, radius, femur, tibia, and fibula.
**In patients with an unfused epiphyseal plate of the involved bone.
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58.5%, for a sharp transition zone of the bone lesion,
and 80.5% and 75.6% for the presence of a soft-tissue
mass, for readers 1 and 2, respectively. Representative
examples are shown in Figs. 1–4. Diagnostic accuracies
for intramedullary fat globules, extramedullary fat glob-
ules, and the penumbra sign were all <50%.
Diagnostic performance diameter soft-tissue mass
Reader 1 judged a soft-tissue mass to be present in 19
patients, of whom 12 with Ewing sarcoma (mean diam-
eter¼ 31 23mm; range¼ 9–79mm), four with
osteomyelitis (mean diameter SD¼ 15 20mm;
range¼ 4–44mm), two with another malignancy (diam-
eters¼ 13 and 34mm for two osteosarcomas), and one
with another benign lesion (diameter¼ 6mm for one
eosinophilic granuloma). AUC of the diameter of the
soft-tissue mass in discriminating Ewing sarcoma from
osteomyelitis was 0.792 (95% CI¼ 0.520–0.948) and an
optimal cut-oﬀ diameter of 6mm yielded sensitivity and
speciﬁcity values of 100% (95% CI¼ 73.4–100) and
75.0% (95% CI¼ 20.3–95.9). AUC of the diameter of
the soft-tissue mass in discriminating Ewing sarcoma or
malignancy from osteomyelitis or other benign lesions




accuracy* (%) Sensitivity* (%) Specificity* (%) PPV* (%) NPV* (%)
Sharp transition
zone bone lesion
1 68.3 (53.0–80.4) 29.4 (13.3–53.1) 95.8 (79.8–99.3) 83.3 (43.7–97.0) 65.7 (49.2–79.2)
2 58.5 (43.4–72.2) 47.1 (26.2–69.0) 66.7 (46.7–82.0) 50.0 (28.0–72.0) 64.0 (44.5–79.8)
Presence of
soft-tissue mass
1 80.5 (66.0–89.8) 82.4 (59.0–93.8) 79.2 (59.5–90.8) 73.7 (51.2–88.2) 86.4 (66.7–95.3)




1 41.5 (27.8–56.6) 100 (81.6–100) 0 (0–13.8) 41.5 (27.8–56.6) NAy




1 41.5 (27.8–56.6) 100 (81.6–100) 0 (0–13.8) 41.5 (27.8–56.6) NAy
2 41.5 (27.8–56.6) 100 (81.6–100) 0 (0–13.8) 41.5 (27.8–56.6) NAy
Absence of
penumbra sign
1 43.9 (29.9–59.0) 100 (81.6–100) 4.2 (1.0–20.2) 42.5 (28.5–57.8) 100 (20.7–100)
2 34.2 (21.6–49.5) 82.4 (59.0–93.8) 0.0 (0.0–13.8) 36.8 (23.4–52.7) 0.0 (0.0–56.2)
*95% CIs in parentheses.
yNot available; insufficient number of categories to perform test.




accuracy* (%) Sensitivity* (%) Specificity* (%) PPV* (%) NPV* (%)
Sharp transition
zone bone lesion
1 64.7 (47.9–78.5) 21.4 (7.6–47.6) 95.0 (76.4–99.1) 75.0 (30.1–95.4) 63.3 (45.5–78.1)
2 58.8 (42.2–73.6) 42.9 (21.4–67.4) 70.0 (48.1–85.5) 50.0 (25.4–74.6) 63.6 (43.0–80.3)
Presence of
soft-tissue mass
1 82.4 (66.5–91.7) 85.7 (60.1–96.0) 80.0 (58.4–91.9) 75.0 (50.5–89.8) 88.9 (67.2–96.9)




1 41.2 (26.4–57.8) 100 (78.5–100) 0 (0–16.1) 41.2 (26.4–57.8) NAy




1 41.2 (26.4–57.8) 100 (78.5–100) 0 (0–16.1) 41.2 (26.4–57.8) NAy
2 41.2 (26.4–57.8) 100 (78.5–100) 0 (0–16.1) 41.2 (26.4–57.8) NAy
Absence of
penumbra sign
1 41.2 (26.4–57.8) 100 (78.5–100) 0 (0–16.1) 41.2 (26.4–57.8) NAy
2 32.4 (19.1–49.2) 78.6 (52.4–92.4) 0.0 (0.0–16.1) 35.5 (21.1–53.1) 0.0 (0.0–56.2)
*95% CIs between parentheses.
yNot available; insufficient number of categories to perform test.
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was 0.829 (95% CI¼ 0.588–0.958) and an optimal cut-
oﬀ diameter of 6mm yielded sensitivity and speciﬁcity
values of 100% (95% CI¼ 76.7–100) and 80.0% (95%
CI¼ 28.8–96.7).
Reader 2 judged a soft-tissue mass to be present in
23 patients, of whom 13 with Ewing sarcoma (mean
diameterSD¼ 65 41mm; range¼ 7–175mm), six
with osteomyelitis (mean diameter SD¼ 33 32mm;
range¼ 9–95mm), two with another malignancy (diam-
eters¼ 54 and 75mm for two osteosarcomas), and two
with another benign lesion (diameters¼ 28 and 29mm
for two eosinophilic granulomas). AUC of the diameter
of the soft-tissue mass in discriminating Ewing sarcoma
from osteomyelitis (excluding all other diagnostic enti-
ties) was 0.795 (95% CI¼ 0.550–0.941) and an optimal
cut-oﬀ diameter of 36mm yielded sensitivity and speci-
ﬁcity values of 84.6% (95% CI¼ 54.5–97.6) and 83.3%
(95% CI¼ 36.1–97.2). AUC of the diameter of the soft-
tissue mass in discriminating Ewing sarcoma or malig-
nancy from osteomyelitis or other benign lesions was
0.833 (95% CI¼ 0.620–0.953) and an optimal cut-oﬀ
diameter of 36mm yielded sensitivity and speciﬁcity
values of 86.7% (95% CI¼ 59.5–98.0) and 87.5%
(95% CI¼ 47.4–97.9).
Fig. 2. A 15-year-old boy with Ewing sarcoma of the left tibia. Coronal T1W (a) and coronal fat-suppressed T2W images (b) show the
lesion in the proximal left tibia. Both observers reported the presence of a sharp transition zone of the bone lesion.
Fig. 1. A 9-year-old girl with Ewing sarcoma in the left humerus. Coronal T1W (a), coronal fat-suppressed T2W (b), axial T1W (c),
and axial gadolinium-enhanced (d) images with caliper measurement (D) show a lesion in the left humerus with a soft-tissue mass
(arrows). Both observers reported the presence of a soft-tissue mass.
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Inter-observer agreement
Inter-observer agreement results of MRI signs are
shown in Table 4. Inter-observer agreements with
regard to the transition zone of the bone lesion
and the presence of a soft-tissue mass were fair and
moderate with k values of 0.307 and 0.470, respectively
(Figs. 1–4). However, inter-observer agreement with
Fig. 3. A 15-year-old girl with bacterial osteomyelitis (Propionibacterium acnes) of the left clavicle and left proximal fourth rib. Coronal
(a) and axial (b) fat-suppressed T2W images and coronal (c) and axial (d) gadolinium-enhanced images shown the lesion in the medial
left clavicle (arrows) and proximal left fourth rib (arrowheads). Both observers reported the presence of a soft-tissue mass.
Fig. 4. A five-year-old boy with osteomyelitis of the left femur (the causative agent remained unclear). Coronal T1W (a), coronal
T2W (b), axial T1W (c), axial fat-suppressed T2W (d), and axial gadolinium-enhanced T1W (e) images show the lesion in the left
femur (arrows). Observer 1 reported the transition zone of the bone lesion to be unsharp and the lack of a soft-tissue mass, whereas
observer 2 reported the opposite for both items.
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regard to the assessment of intramedullary fat globules
and the penumbra sign was poor, with k values of 0.000
and 0.038, respectively. Inter-observer agreement
with regard to the assessment of extramedullary fat
globules could not be assessed due to the lack of posi-
tive scores. In 15 patients, both observers 1 and 2
judged a soft-tissue mass to be present. In these 15
patients (who all had undergone gadolinium-enhanced
MRI), mean inter-observer diﬀerence in soft-tissue
mass diameter measurement limits of agreement was
35.0 75.0mm.
Discussion
The results of this study show that the presence of a
soft-tissue mass is the most valuable MRI sign for dis-
criminating Ewing sarcoma from osteomyelitis, with
diagnostic accuracies of around 80%. This ﬁnding is
also applicable to the discrimination of Ewing sarcoma
or other malignancy from osteomyelitis or other benign
lesions. The transition zone of the bone lesion was only
moderately useful with diagnostic accuracies of around
60%. Diagnostic accuracies for intramedullary and
extramedullary fat globules and the penumbra sign
were all< 50%. None of the evaluated MRI signs
reached a consistently high PPV or NPV to reliably
rule in or rule out Ewing sarcoma. Yet another import-
ant ﬁnding is that in patients with a soft-tissue mass
adjacent to the involved bone, additional soft-tissue
mass diameter measurements perpendicular to the
long axis of the involved bone were found to be
useful in diﬀerentiating Ewing sarcoma from osteomye-
litis, with larger diameters found in Ewing sarcoma.
Note that osteomyelitis not uncommonly presents
with an adjacent soft-tissue mass (in around 25% of
cases in the present study) (7,8) and that the size of
the soft-tissue mass may thus be diagnostically helpful.
However, no cut-oﬀ values can currently be recom-
mended, because inter-observer agreement was low
with mean diﬀerence in soft-tissue mass diameter
measurement limits of agreement of 35.0 75.0mm.
Inter-observer agreement with regard to the presence of
a soft-tissue mass and transition zone was also rela-
tively low with fair to moderate k values.
Both the present study and two previous studies on
this topic (7,8) included patients with a bone lesion of
unknown nature with a diﬀerential diagnosis of both
Ewing sarcoma and osteomyelitis, but only the former
did not exclude patients who were eventually diagnosed
with another entity. Moreover, the present study used
strict enrollment criteria to only include patients in
whom the diagnosis was still unclear while excluding
patients in whom the diagnosis was already proven or
suspected based on pathological, clinical, or other ima-
ging ﬁndings. Therefore, the present results may have
greater clinical applicability. Nevertheless, the studies
by Henninger et al. (7) and McCarville et al. (8) also
reported relatively high diagnostic accuracies for the
presence of a soft-tissue mass in diagnosing Ewing sar-
coma of 78.6% (95% CI¼ 60.1–89.8) and 75.5% (95%
CI¼ 62.4–85.1), respectively. The biggest discrepancy is
that Henninger et al. (7) reported the transition zone of
the bone lesion to have a diagnostic accuracy of 100%
(95% CI¼ 87.9–100), while McCarville et al. (8)
reported a diagnostic accuracy of only 45.3% (95%
CI¼ 32.4–58.6) for this sign, the latter more in line
with the ﬁndings of the present study. Yet another dis-
crepancy between Henninger et al.’s study (7) and the
present study is that the former reported that overall
MRI inter-observer reliability was good (with a k value
of 0.7590), while the latter found a relatively low inter-
observer agreement. The penumbra sign and the pres-
ence of intramedullary or extramedullary fat globules
have also been proposed as speciﬁc signs for osteomye-
litis in previous studies in which only osteomyelitis
patients were included, and these signs have also been
suggested as potentially useful for diﬀerentiating osteo-
myelitis from malignancy (9,10). However, none of
these signs were found to be of diagnostic value in the
present study.
This study had several limitations. First, the results
of this study are only applicable to patients aged 30
years (this upper limit was chosen because the vast
majority of Ewing sarcomas occur below this age
(1,2)) who present with a bone lesion of unknown
nature with both Ewing sarcoma and osteomyelitis in
the diﬀerential diagnosis. The ﬁndings are not applic-
able to patients aged >30 years or with a bone lesion in
which Ewing and osteomyelitis are not in the diﬀeren-
tial diagnosis based on clinical or radiographic ﬁndings.
Second, radiographs were not analyzed, but previous
work has already shown that radiography has no inde-
pendent diagnostic value compared to MRI in this set-
ting (8). Third, MRI protocols were not uniform, since
11 of 41 patients had undergone MRI elsewhere before
referral to our hospital; this is a weakness in the present
Table 4. Inter-observer agreement results of MRI signs.
MRI sign Kappa*
Sharp transition zone bone lesion 0.307 (0.0227–0.637)







Absence of penumbra sign –0.038 (1.004–0.928)
*95% CIs between parentheses.
yNot available; insufficient number of categories to perform test.
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study but reﬂects clinical practice. Fourth, the relatively
low inter-observer agreement and particularly the opti-
mal cut-oﬀ of the size of the soft-tissue mass for dis-
criminating Ewing sarcoma from osteomyelitis, require
further optimization and investigation. Fifth, MRI
scans were interpreted by two musculoskeletal radiolo-
gists who work in a tertiary referral center for bone
tumors. Further research should also investigate the
diagnostic performance and inter-observer agreement
of MRI among general radiologists who less frequently
encounter bone tumors in this patient population.
In conclusion, the presence and size of a soft-tissue
mass, and to a lesser extent the sharpness of the tran-
sition zone, are useful MRI signs to diﬀerentiate Ewing
sarcoma from osteomyelitis, but inter-observer agree-
ment is relatively low. Other MRI signs are of no value
in this setting.
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